Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1946 1
1947 2
1949 1
1951 1
1952 1
1954 1
1957 1
1958 1
1966 1
1967 2
1968 3
1969 1
1970 2
1971 1
1972 1
1973 1
1975 2
1977 1
1978 1
1979 1
1980 1
1981 2
1982 2
1983 1
1984 1
1985 2
1991 2
1992 6
1993 6
1994 9
1995 8
1996 3
1997 4
1998 7
1999 4
2000 4
2001 10
2002 9
2003 7
2004 4
2005 7
2006 11
2007 18
2008 19
2009 14
2010 8
2011 13
2012 13
2013 11
2014 7
2015 12
2016 7
2017 11
2018 4
2019 5
2020 9
2021 3
2022 5
Text availability
Article attribute
Article type
Publication date

Search Results

270 results
Results by year
Filters applied: . Clear all
Page 1
Overall mortality.
Moore DF, Steen VD. Moore DF, et al. J Scleroderma Relat Disord. 2021 Feb;6(1):3-10. doi: 10.1177/2397198320924873. Epub 2020 Jun 8. J Scleroderma Relat Disord. 2021. PMID: 35382244 Free PMC article.
DARPA Nest.
Moore DF, Miranda R, Ling GS. Moore DF, et al. IEEE Pulse. 2012 Jan;3(1):14. doi: 10.1109/mpul.2011.2181030. IEEE Pulse. 2012. PMID: 22442863 No abstract available.
Racial Disparities in Systemic Sclerosis.
Moore DF, Steen VD. Moore DF, et al. Rheum Dis Clin North Am. 2020 Nov;46(4):705-712. doi: 10.1016/j.rdc.2020.07.009. Epub 2020 Sep 8. Rheum Dis Clin North Am. 2020. PMID: 32981647 Review.
Cranial aerocele.
JELSMA F, MOORE DF. JELSMA F, et al. Among authors: moore df. Am J Surg. 1954 Mar;87(3):437-51. doi: 10.1016/s0002-9610(54)90147-6. Am J Surg. 1954. PMID: 13124659 No abstract available.
Continuous versus intermittent BRAF and MEK inhibition in patients with BRAF-mutated melanoma: a randomized phase 2 trial.
Algazi AP, Othus M, Daud AI, Lo RS, Mehnert JM, Truong TG, Conry R, Kendra K, Doolittle GC, Clark JI, Messino MJ, Moore DF Jr, Lao C, Faller BA, Govindarajan R, Harker-Murray A, Dreisbach L, Moon J, Grossmann KF, Ribas A. Algazi AP, et al. Among authors: moore df jr. Nat Med. 2020 Oct;26(10):1564-1568. doi: 10.1038/s41591-020-1060-8. Epub 2020 Oct 5. Nat Med. 2020. PMID: 33020646 Free PMC article. Clinical Trial.
The cerebral vasculopathy of Fabry disease.
Moore DF, Kaneski CR, Askari H, Schiffmann R. Moore DF, et al. J Neurol Sci. 2007 Jun 15;257(1-2):258-63. doi: 10.1016/j.jns.2007.01.053. Epub 2007 Mar 23. J Neurol Sci. 2007. PMID: 17362993 Review.
Neurological manifestations of Fabry disease.
Schiffmann R, Moore DF. Schiffmann R, et al. Among authors: moore df. In: Mehta A, Beck M, Sunder-Plassmann G, editors. Fabry Disease: Perspectives from 5 Years of FOS. Oxford: Oxford PharmaGenesis; 2006. Chapter 22. In: Mehta A, Beck M, Sunder-Plassmann G, editors. Fabry Disease: Perspectives from 5 Years of FOS. Oxford: Oxford PharmaGenesis; 2006. Chapter 22. PMID: 21290698 Free Books & Documents. Review.
Military traumatic brain injury and blast.
Moore DF, Jaffee MS. Moore DF, et al. NeuroRehabilitation. 2010;26(3):179-81. doi: 10.3233/NRE-2010-0553. NeuroRehabilitation. 2010. PMID: 20448307
Enzyme replacement therapy in Fabry disease.
Brady RO, Murray GJ, Moore DF, Schiffmann R. Brady RO, et al. Among authors: moore df. J Inherit Metab Dis. 2001;24 Suppl 2:18-24; discussion 11-2. doi: 10.1023/a:1012451320105. J Inherit Metab Dis. 2001. PMID: 11758675 Review.
Solar particle event storm shelter requirements for missions beyond low Earth orbit.
Townsend LW, Adams JH, Blattnig SR, Clowdsley MS, Fry DJ, Jun I, McLeod CD, Minow JI, Moore DF, Norbury JW, Norman RB, Reames DV, Schwadron NA, Semones EJ, Singleterry RC, Slaba TC, Werneth CM, Xapsos MA. Townsend LW, et al. Among authors: moore df. Life Sci Space Res (Amst). 2018 May;17:32-39. doi: 10.1016/j.lssr.2018.02.002. Epub 2018 Feb 21. Life Sci Space Res (Amst). 2018. PMID: 29753411 Review.
270 results